Pyxis Oncology, Inc. Common Stock (PYXS)
Pyxis Oncology, Inc. Common Stock (PYXS) has reported earnings 19 times since Nov 15, 2021. The stock moves an average of ±5.24% the day after reporting, closing higher 42.1% of the time. Its largest post-earnings gain was +7.96% (Aug 14, 2025) and its largest decline was -15.46% (May 14, 2026). The next earnings report is predicted for 2026-08-14 (estimated).
Earnings reactions
How PYXS moved on each past earnings report.
Earnings Impact
Total Earnings
19
Avg Abs. Movement
±5.24%
Positive %
42.1%
Negative %
57.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 14, 2026 | ☀ PRE | -15.46% | open_in_new |
| Mar 23, 2026 | ☀ PRE | -4.7% | open_in_new |
| Nov 03, 2025 | ☀ PRE | +6.01% | open_in_new |
| Aug 14, 2025 | ☽ POST | +7.96% | open_in_new |
Earnings Count
19
Total earnings in dataset
Avg Abs. Movement
±5.24%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
9 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 3 | 20260710 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260710 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 8-K | 20260702 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260702 | open_in_new SEC.gov |
| 144 | 20260630 | open_in_new SEC.gov |
| 8-K | 20260615 | open_in_new SEC.gov |
| 10-Q | 20260514 | open_in_new SEC.gov |
| 8-K | 20260514 | open_in_new SEC.gov |
Frequently asked about PYXS earnings
When does Pyxis Oncology, Inc. Common Stock report earnings next? expand_more
Pyxis Oncology, Inc. Common Stock (PYXS)'s next earnings date is estimated for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does PYXS stock move after earnings? expand_more
Over 19 reports, PYXS has moved an average of ±5.24% the session after earnings, closing higher 42.1% of the time.
What was PYXS's biggest post-earnings move? expand_more
PYXS's largest post-earnings gain on record was +7.96% on Aug 14, 2025, and its largest decline was -15.46% on May 14, 2026.
Where can I find Pyxis Oncology, Inc. Common Stock's SEC filings? expand_more
All of Pyxis Oncology, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right